-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Efforts are increasing to identify potential risk factors for cognitive decline and the development of dementia in Parkinson's disease (PD)
.
About 30-40% of Parkinson's patients have cognitive impairment, and the prevalence increases over the course of the disease, reaching 50% after 10 years and 80% 20 years after diagnosis
.
Cognitive conditions associated with Parkinson's disease are heterogeneous
.
Deficits in executive function as well as attention and working memory frequently appear in the early stages of PD due to known anterior striatal dysfunction
.
Patients can be classified as tremor-dominant (TR-D), postural instability disorder (PIGD), or nondetermined (ND) motor phenotype
.
Patients have also been classified into tremor-dominant, bradykinetic, and mixed phenotypes
.
Likewise, motor phenotype may also influence the progression of cognitive impairment, as evidence suggests that patients with PIGD not only exhibit faster cognitive decline, but also have a greater risk of dementia and higher rates of depression
.
This may be particularly relevant to the role of the motor phenotype and the progression of cognitive impairment, since patients initially presenting with TR-D tend to convert to PIGD over the course of the disease
.
Here, Jennifer Michels of RWTH Aachen University Hospital in Germany used long-term data from the DEMPARK/LANDSCAPE study to assess the predictive value of cognitive impairment progression and exercise phenotypes for cognitive decline in PD
.
They included six-year longitudinal data on demographic, clinical, and neuropsychological data from 711 PD patients (age: M = 67.
57; 67.
4% were male)
.
And calculated the Z-transform composite score in the cognitive domain
.
To minimize missing data and dropouts, they used linear mixed models to evaluate three-year follow-up data from 442 PD patients for the specific role of exercise phenotype on cognitive decline (age: M = 66.
10; 68.
6% male)
.
They found that motor symptoms increased over the course of the disease, while MMSE and PANDA remained stable across all subgroups
.
.
After a three-year follow-up, PIGD patients showed a significant decrease in overall cognitive ability, and motor phenotypes differed in attention (β=-0.
08, SE=0.
In addition, PIGD patients more often experience difficulties in daily life
.
The significance of the study lies in the discovery that, over a three-year period, different PD motor phenotypes have distinct patterns of neuropsychological progression , with early executive deficits producing more amnestic features later in the process
.
In particular, patients with PIGD worsened over time compared with patients with TR-D and ND, highlighting a greater risk of dementia with this motor phenotype
.
Different PD motor phenotypes have distinct patterns of neuropsychological progression over a three-year period
Original source:
leave a message here